Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity

We have developed an immunotherapy in which tumor cells transfected with syngeneic major histocompatibility complex (MHC) class II genes are cell-based vaccines for the treatment of established tumor and metastatic disease. If this strategy is to be used clinically, convenient methods for generating...

詳細記述

書誌詳細

出版年:	Proc Natl Acad Sci U S A
主要な著者:	Armstrong, Todd D., Clements, Virginia K., Martin, Brian K., Ting, Jenny P.-Y., Ostrand-Rosenberg, Suzanne
フォーマット:	Artigo
言語:	Inglês
出版事項:	National Academy of Sciences 1997
主題:	Biological Sciences
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC21254/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9192661/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.94.13.6886
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!